AI chart prep boosts oncology enrollment
Caroline Zhang, CEO of Knowtex, on going from AI medical scribe to AI lab
This shows the wedge is no longer note taking, it is finding revenue and treatment opportunities buried in the chart before the visit starts. In practice, Knowtex is scanning labs, pathology, imaging, genetics, and prior notes during chart prep, then flagging trial eligible patients and routing follow up to research staff. In oncology clinics where nobody has time to manually read hours of charts, that can lift enrollment simply by catching patients who were already there but previously went unseen.1 2 3 4
- The 60% figure sits inside a broader workflow, not a standalone trial tool. Knowtex says it shows a visit agenda and recommended trials before the encounter, then after the visit can send messages and email to the clinical research coordinator and generate a trial workup.1 2
- That matters because trial matching is mostly a staffing problem. The practice baseline was constrained by doctors who could not review eight hours of charts after clinic and by too few research coordinators. The product improves yield by doing the first pass screening work automatically.1 2
- It also explains why AI scribe vendors are moving up the workflow. Abridge, Ambience, and Freed all started with documentation, but the category is being pushed toward chart prep, coding, orders, and specialty workflows. Trial matching is one of the clearest examples of where a deeper oncology workflow can justify paid software.1 5 6
The next step is that trial matching becomes a standard feature inside the clinical workstation, especially in oncology where missed enrollment has direct patient and research value. Companies that can combine ambient visit data with deep record access and coordinator workflows will move from saving physicians time to shaping which patients get advanced therapies and which platforms control research dollars.1 3 4 6